Skip to main content
Premium Trial:

Request an Annual Quote

MediSapiens to Develop Cancer Genomics Data-Management Platform for Bayer

Premium

MediSapiens said this week that it is developing a platform to support cancer genomics data management and analysis for Bayer Healthcare.

The Finnish bioinformatics company said that it will work with Bayer to develop a platform based on MediSapiens' existing infrastructure that will help the pharmaceutical firm's researchers "more effectively" use their oncology data in both preclinical and clinical research settings.

MediSapiens develops web applications for genomics, pharmaceutical research, and personalized medicine. The company recently released a map of human gene expression for public use through its Transcriptome viewer tool (BI 9/30/2011).

The Bayer project will allow MediSapiens to use the expertise it has gleaned from building and managing its unified gene expression database, Sami Kilpinen, MediSapiens chief scientific officer, said in a statement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.